Literature DB >> 21092391

Socio-economic aspects of neglected diseases: sleeping sickness and visceral leishmaniasis.

M Boelaert1, F Meheus, J Robays, P Lutumba.   

Abstract

Several tropical diseases that are essentially poverty-related have recently gained more attention under the label of 'neglected tropical diseases' or NTD. It is estimated that over 1000 million people currently suffer from one or more NTD. Here, the socio-economic aspects of two NTD - human African trypanosomiasis and human visceral leishmaniasis - are reviewed. Both of these diseases affect the poorest of the poor in endemic countries, cause considerable direct and indirect costs (even though the national control programmes tend to provide free care) and push affected households deeper into poverty.

Entities:  

Mesh:

Year:  2010        PMID: 21092391     DOI: 10.1179/136485910X12786389891641

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  15 in total

Review 1.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.

Authors:  Thomas Seebeck; Geert Jan Sterk; Hengming Ke
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

3.  Visceral leishmaniasis with Roth spots.

Authors:  Jagdish Meena; Monica Juneja; Devendra Mishra; Pallavi Vats; Arti Pawaria
Journal:  Oxf Med Case Reports       Date:  2014-09-16

4.  From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study.

Authors:  Alain Mpanya; David Hendrickx; Sylvain Baloji; Crispin Lumbala; Raquel Inocêncio da Luz; Marleen Boelaert; Pascal Lutumba
Journal:  PLoS Negl Trop Dis       Date:  2015-04-09

5.  Diagnostic work-up of neurological syndromes in a rural African setting: knowledge, attitudes and practices of health care providers.

Authors:  Alain Mpanya; Marleen Boelaert; Sylvain Baloji; Junior Matangila; Symphorien Lubanza; Emmanuel Bottieau; François Chappuis; Pascal Lutumba; David Hendrickx
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

6.  Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study.

Authors:  Shyam Sundar; Krishna Pandey; Chandreshwar Prasad Thakur; Tara Kant Jha; Vidya Nand Ravi Das; Neena Verma; Chandra Shekhar Lal; Deepak Verma; Shahnawaz Alam; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

Review 7.  Health economic evaluations of visceral leishmaniasis treatments: a systematic review.

Authors:  Daniel S Marinho; Carmen N P R Casas; Claudia C de A Pereira; Iuri C Leite
Journal:  PLoS Negl Trop Dis       Date:  2015-02-27

8.  Incorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in Uganda.

Authors:  Finola Hackett; Lea Berrang Ford; Eric Fèvre; Pere Simarro
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

9.  Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies.

Authors:  Christian Burri; Patrick D Yeramian; James L Allen; Ada Merolle; Kazadi Kyanza Serge; Alain Mpanya; Pascal Lutumba; Victor Kande Betu Ku Mesu; Constantin Miaka Mia Bilenge; Jean-Pierre Fina Lubaki; Alfred Mpoo Mpoto; Mark Thompson; Blaise Fungula Munungu; Francisco Manuel; Théophilo Josenando; Sonja C Bernhard; Carol A Olson; Johannes Blum; Richard R Tidwell; Gabriele Pohlig
Journal:  PLoS Negl Trop Dis       Date:  2016-02-16

10.  The monetary value of human lives lost due to neglected tropical diseases in Africa.

Authors:  Joses Muthuri Kirigia; Gitonga N Mburugu
Journal:  Infect Dis Poverty       Date:  2017-12-18       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.